Acellera tests 7 LLM+harness combos on drug discovery: one RTX 5090 holds up

gdefabritiis · x · 2026-09-10

Acellera founder Gianni De Fabritiis reports the company burns 1B tokens/day via agentic workflows, expected to grow 10x — making frontier-only usage unaffordable. He tested how far self-hosted models, including single-GPU ones, can go.

The experiment: 7 LLM + harness combinations (Claude, ChatGPT, PlayMolecule® AI) on a demanding IL-23 (IL23R-p19, psoriasis) drug discovery task — retrieving literature and structural data to produce a measurable target product profile and small-molecule strategy. Several surprises, including what a single RTX 5090 could produce. Blog and comparative reports are public.

Related event: Acellera Tests Local LLM Drug Discovery on a Single RTX 5090(2 posts)→

Original post →

More from Infra

Infra channel →